New York, NY, United States of America

Robert Blue


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Panama City, FL (US) (2012)
  • New York, NY (US) (2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert Blue

Introduction

Robert Blue is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of thrombotic disorders. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Robert Blue's latest patents include "Alpha-IIb-beta-3 inhibitors and uses thereof." This invention relates to methods for the treatment or prophylaxis of thrombotic disorders through the administration of alpha-IIB-beta-3 inhibitor compounds. The methods are useful for treating conditions such as stroke, myocardial infarction, unstable angina, peripheral vascular disease, abrupt closure following angioplasty or stent placement, and thrombosis resulting from vascular surgery. Another patent under his name also focuses on alpha-IIB-beta-3 inhibitors, detailing compounds and compositions that inhibit and reduce platelet deposition, adhesion, and aggregation. This invention further includes methods for screening compounds useful for these purposes.

Career Highlights

Robert Blue is affiliated with The Rockefeller University, where he conducts his research and development. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Robert collaborates with Barry S Coller, a fellow researcher, to enhance the impact of their work in the field of thrombotic disorders.

Conclusion

Robert Blue's innovative patents and research at The Rockefeller University highlight his dedication to improving medical treatments for thrombotic disorders. His contributions are paving the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…